[TABLE="class: components"]
[TR="class: odd"]
[TD="class: nameCol srchbl"]LYME DISEASE IGG/IGM
[/TD]
[TD="class: valueCol"]
[/TD]
[TD="class: rangeCol"] [/TD]
[TD="class: flagCol"][/TD]
[/TR]
[TR="class: tableRowMessage comments odd"]
[TD="class: srchbl, colspan: 4"]Note
REFERENCE RANGE: <=0.90
INTERPRETIVE CRITERIA:
<= 0.90 NEGATIVE
0.91-1.09 EQUIVOCAL
>= 1.10 POSITIVE
The use of purified VlsE-1 and PepC10 antigens in
this assay provides improved specificity compared
to assays that utilize whole cell lysates of B.
burgdorferi, the causative agent of Lyme disease,
and slightly better sensitivity compared to the
C6 antibody assay.
As recommended by the Food and Drug
Administration (FDA), all samples with positive
or equivocal results in a Borrelia burgdorferi
antibody EIA (screening) will be tested using a
blot method. Positive or equivocal screening test
results should not be interpreted as truly
positive until verified as such using a
supplemental assay (e.g., B. burgdorferi blot).
The screening test and/or blot for B. burgdorferi
antibodies may be falsely negative in early
stages of Lyme disease, including the period when
erythema migrans is apparent.
----
I resulted at < or = 0.90 . Therefore no Western Blot was done. I'm not clear if WB or tests for the other tick borne illnesses need to be done.
[/TD]
[/TR]
[/TABLE]
